Volume | 1,990,262 |
|
|||||
News | - | ||||||
Day High | 78.16 | Low High |
|||||
Day Low | 77.09 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Hologic Inc | HOLX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
77.47 | 77.09 | 78.16 | 77.96 | 77.35 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
21,155 | 1,990,262 | $ 77.63 | $ 154,513,578 | - | 64.02 - 87.88 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:46:30 | 2 | $ 74.34 | USD |
Hologic (HOLX) Options Flow Summary
Hologic Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
18.29B | 234.73M | - | 4.05B | 456M | 1.94 | 40.12 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hologic News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOLX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 75.04 | 78.16 | 74.725 | 76.05 | 1,464,310 | 2.92 | 3.89% |
1 Month | 74.41 | 78.16 | 73.05 | 75.62 | 1,734,011 | 3.55 | 4.77% |
3 Months | 72.27 | 78.16 | 70.73 | 74.29 | 1,834,054 | 5.69 | 7.87% |
6 Months | 69.35 | 78.16 | 64.02 | 71.83 | 1,858,669 | 8.61 | 12.42% |
1 Year | 79.38 | 87.88 | 64.02 | 74.92 | 1,711,758 | -1.42 | -1.79% |
3 Years | 72.78 | 87.88 | 59.78 | 73.11 | 1,754,888 | 5.18 | 7.12% |
5 Years | 47.08 | 87.88 | 26.49 | 65.16 | 1,901,796 | 30.88 | 65.59% |
Hologic Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |